Member Info for Chelsea11

Dalester - do you not think the CEO would have been instrumental in the CVLP tie-up?

Thanks TF. I’d be amazed if Scancell are not a principal focus amongst the “ multiple pharmaceutical development programs”. If you go to the Pharmajet website you’ll see the Scancell logo is actually top of the pops on the home page and then if you search for the company, look how many articles there have been historically, including quite recent.

That presentation, just a few days away now, will be another publicity boost.

Terrific week here with the leftfield, unexpected CVLP news and now the presentation announced to capitalise on that. Going places……….

HAGW with family.

“The SCOPE trial - more details coming soon”

Taken from the link below. I assume that page will soon be updated with the 7 CVLP supported trials (and any additional thereafter). Not clear to me if any of those 7 would be in addition to existing non-CVLP sites. Interestingly the map illustrates 55 trial sites and if you count up the sites for Colorectal shown below on the same page, there’s 48 of those. 48 + 7 =55. Point I’m making is that this page may soon be updated with the sites relevant to the SCOPE trial. No idea if clinicaltrials.gov would also be updated but guess so if there are changes.

https://www.southampton.ac.uk/ctu/cancer-vaccine-launch-pad.page#supported_vaccine_trials

And where is Captain Emoji?

Sure he'll soon be back an all.

NTVO have the pleasure of Fonzi today. He’s over there posting rockets and explosions every few minutes. More of the same quality investment advice.

Night out with Ruck

And make sure TF is near the top as well for blaming all his laptop troubles on the website 😂

Dracula for me please 😂

43538 top up for me

I did get an apology today from the Bioindustry Association (BIA) about the 404 error we saw on their website on Friday, to the link CW provided. Good of them to respond. I did say I would post any response here. They provided me with the link below which I assume is the same content.

https://www.bioindustry.org/resource/partnership-with-nhs-cancer-vaccine-launch-pad-enabling-fast-tracked-access-for-melanoma-patients.html

The Fonz, or Ralph Malph.

You decide!

Fonzi - everyone here knows you’re a Trader. Nowt wrong with that but just calling out you have no view here past the end of next week. Your cross ramps across multiple other boards gives your position away.

It’s very evident that Scancell today are a very different animal to the version prior to L’Hullier’s arrival. That isn’t a slur on Lindy, as todays leap forward would clearly not have happened without her brilliant mind but commercially speaking, a very different animal.

Congratulations to the whole team behind todays news.

Just in case an RNS doesn’t appear, I have mailed bioindustry.org to ask why the link no longer works. It’s not impossible that they aren’t even aware of the 404 error, although I doubt that.

It also crossed my mind that bioindustry released their article as planned to agreed timelines but Scancell held the RNS publication for some reason.

Anyway, I’ll post any response I get from bioindustry here, should they reply.

Nice find Cleaner (now you weren’t expecting that from me, were you!)

As an aside, mid-2025 is now actually just 12 weeks away (officially 2nd July).

Any pop-ups TF, or can you read that one ok? 😇

The sausage jokes are now on a roll

The use of sausages is definitely the wurst way to make an argument.

Today’s RNS is a positive case-study for Tristel HLD products. Whilst is perhaps won’t directly influence the US FDA 510(k) filing for Tristel OPH, a high-level disinfectant (HLD) foam for use on ophthalmic medical devices, I can’t see how it can do any harm either. We know from previous communication from the company that they are expecting FDA clearance for ophthalmic by Summer this year. There seems to be senior management confidence that Trumps tariffs will not negatively impact plans, given manufacturing is done in the US.